The complexity of molecular processes in osteoarthritis of the knee joint

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease causing significant pain and disability worldwide.
• Current OA treatments do not halt disease progression, necessitating research into underlying molecular mechanisms.
• Identifying molecular targets is crucial for developing novel, effective OA therapies.

Purpose of the Study:

• To analyze the molecular profile of OA by measuring inflammatory cytokines and matrix metalloproteinases (MMPs) in joint tissues.
• To correlate these molecular markers with radiological OA severity, clinical symptoms, and patient demographics.
• To explore potential therapeutic targets based on identified molecular correlations.

Main Methods:

• Collected 50 samples of meniscus, ACLs, and articular surfaces from patients undergoing knee arthroplasty.
• Utilized Enzyme-Linked Immunosorbent Assay (ELISA) for cytokines (IL-1β, IL-6, TNF-α, TGF-β1).
• Employed LUMINEX technology for MMPs (MMP-1, -2, -3, -9, -13) and correlated data with clinical and radiological assessments.

Main Results:

• Found strong positive correlations between pro-inflammatory cytokines and MMPs, notably TNF-α with MMP-2/MMP-13 and IL-6 with MMP-13.
• MMP-13 positively correlated with MMP-1, MMP-2, and MMP-9.
• Negative correlation observed between clinical OA severity (WOMAC scale) and TNF-α/MMP-1 levels. Lower TNF-α in NSAID users; decreased MMP-2 correlated with higher radiological OA severity.

Conclusions:

• Specific MMPs and inflammatory cytokines are significantly correlated with OA progression and clinical presentation.
• These molecular markers, particularly MMP-13 and TNF-α, represent potential targets for future OA therapies.
• Further research into these molecular pathways could lead to treatments that modify OA disease progression.